What is a reasonable EBITDA multiple for a small business?

You’re sitting across from a seller’s advisor who just anchored their valuation at 5.2x EBITDA. Your first instinct: is that reasonable for a $3M business, or are they fishing for an inflated price? The problem is that “EBITDA multiple” is shorthand for dozens of variables—industry, growth rate, customer concentration, working capital needs, buyer’s cost of capital—and the micro-markets under $10M are opaque. Unlike public comps or mega-deals with full Quality of Earnings engagements, small acquisitions often hinge on a number that nobody fully justifies. This article cuts through that fog by showing you how multiples actually work in smaller deals, what moves them up or down, and how to calculate and challenge the specific multiple you’re staring at.

The Core Formula: How EBITDA Multiples Work

An EBITDA multiple is simply this:

Enterprise Value = EBITDA × Multiple

If a business generated $1M in normalized EBITDA and you’re paying 4.5x, you’re paying $4.5M. That multiple represents how many years of current earnings the buyer is willing to pay upfront. A 3x multiple says the earnings will pay back the investment in three years (ignoring interest, taxes, and other nuances). A 6x multiple means five years—or that the buyer expects faster growth, lower risk, or both.

The multiples that move in small deals range from 2.0x to 6.5x, with 3.5x to 4.5x being the statistical center for most services and light manufacturing under $10M. But centering on an average is a fool’s errand if you don’t know why a specific deal sits above or below it.

What Actually Drives the Multiple: The Six Levers

Every time a multiple is offered, one or more of these factors is at play. Understanding which ones apply to your target gives you the foundation to push back credibly.

1. Customer Concentration Risk

If one customer is 40% of revenue, your multiple is already capped. Most buyers subtract 0.5x to 1.0x from their base bid for concentration above 25–30%. Why? If that customer leaves, EBITDA collapses. A business where the top three customers are each under 15% of revenue can command a premium of 0.3x to 0.5x.

2. Revenue Stability and Predictability

Recurring revenue (contracts, subscriptions, managed services) trades at a 0.75x to 1.5x premium over transactional revenue in the same sector. A staffing or consulting firm with 60% contract backlog is worth more per dollar of EBITDA than one that starts from zero each quarter. Project-based businesses sit lower because future earnings are uncertain.

3. Growth Rate and Trajectory

Buyers pay for growth. A business growing 15–20% year-over-year can justify 0.5x to 1.0x more than a flat peer. Growth must be real, documented over at least two years, and repeatable—one good year doesn’t count. Mature, slow-growth businesses (single digits) often sit at 2.5x to 3.5x; high-growth businesses (15%+ CAGR) can reach 5.0x to 6.0x in the same industry.

4. Management and Key Person Dependency

If the owner does 80% of the selling, the business is worth less because buyer risk is higher. Systems, documented processes, and a management team in place add 0.3x to 0.75x. A business that can run without the founder for a month is already significantly de-risked.

5. Competitive Moat and Differentiation

Proprietary products, strong brand, or deep switching costs are worth real multiples. A website design agency is commoditized; a firm with a patented SaaS tool for a niche vertical commands premium pricing. The question isn’t “is this a good business?” but “how easy is it for a competitor to replicate?” Hard-to-replicate earns 0.4x to 0.8x more.

6. Debt and Working Capital Requirements

A business that requires $500K in receivables financing to run has a lower “quality” of EBITDA than one that’s cash-on-delivery. Similarly, businesses that carry inventory or large payables cycles reduce the actual cash available to service debt. Adjusting EBITDA for working capital peg expectations (usually 10–15% of growth or as a percentage of revenue) can shift the effective multiple by 0.3x to 0.6x.

Benchmarking: What’s Normal for Your Target?

You can’t make a defensible argument without knowing what the market actually pays. Here’s how to build a realistic range:

• SEC Filings & Precedent Transactions: Search for similar acquisitions in the past 24 months on SEC EDGAR (look at 8-K filings and proxy statements where smaller deals are disclosed). Industry-specific databases like those from the International Business Brokers Association occasionally publish ranges by sector.
• Broker Insight: Call three brokers who specialize in your industry in your region. Ask them bluntly: “What multiple range are you seeing for a $2–4M EBITDA business in [your sector] right now?” They won’t give you a specific deal, but they’ll anchor you to market reality.
• SBA Lending Appetite: Check what SBA lenders are willing to finance for similar businesses. If they’ll only leverage to 2.5x EBITDA after equity, that’s a signal about perceived risk—and what the buy-side sees as “safe” value.
• Rule of Thumb (with Caution): Some sectors trade on revenue multiples or cash flow multiples. Manufacturing often uses 3.0x to 4.5x EBITDA; staffing or call centers might be 2.5x to 3.5x; high-margin software or consulting can hit 5.0x to 7.0x. But rule-of-thumb is a starting point, not law—always adjust for the specifics of your target.

The Normalization Problem: Why Your EBITDA Might Be Wrong

A multiple is only as good as the EBITDA number it’s applied to. This is where small-deal buyers often stumble: you’re handed an “adjusted EBITDA” from the seller’s accountant, you apply a market multiple, and six months later you realize it was padded with add-backs that don’t repeat.

Common traps:

• One-time Costs Claimed as Recurring: A seller adds back $50K in legal fees because “we won’t need them again.” Wrong—contract disputes, IP work, and litigation happen in every market. Use a normalized cost.
• Owner Draws & Discretionary Spending: The owner paid $150K for a “company car” or “consulting” by their spouse. Legitimate add-backs, but be aggressive about what actually goes away post-acquisition.
• Timing Tricks: A one-time customer payment that inflated Q4 revenue, or a supplier payment that was deferred into the next year. Smooth out at least two years of trailing actuals.

Before you apply any multiple, ensure your normalized EBITDA is defensible—ideally by having a licensed CPA review it independently, not just accepting management’s word.

A Worked Example

Say you’re looking at a $2M-revenue marketing services firm with $400K in EBITDA before adjustments. After normalization (removing one-time severance, adding back the owner’s excess distributions, and smoothing revenue), you land on $380K normalized EBITDA.

The seller’s advisor offers 4.5x, implying a $1.71M Enterprise Value.

Now you fact-check the multiple:

• Customer Concentration: Top three clients = 55% of revenue (red flag). Subtract 0.75x.
• Growth: Flat for two years (no growth premium). Base 3.5x.
• Management: Owner does 70% of client work (key person risk). Subtract 0.5x.
• Recurring Revenue: 40% of revenue is retainer-based (modest positive). Add 0.25x.

Your justified range: 3.5x − 0.75x − 0.5x + 0.25x = 2.5x, or $950K Enterprise Value.

The seller’s 4.5x number assumed no concentration risk, no key person dependency, and growth that isn’t there. Your calculation is quantified pushback, not just opinion.

When to Walk Away from a Multiple

Some multiples are defensible outliers; most aren’t. Walk away if:

• The multiple is 1.5x higher than broker comps for your sector and deal size, with no corresponding narrative (growth, moat, defensibility).
• Normalized EBITDA includes add-backs that the buyer themselves has flagged as risky or one-time.
• Growth claims rely on future upside (“they can do $500K more revenue”) rather than documented historical trend.
• Key person dependency is extreme and the seller won’t commit to staying; your discount should be 0.8x to 1.5x higher than a stable-management comp.

Frequently Asked Questions

What’s the difference between an EBITDA multiple and a price-to-earnings (P/E) ratio?

EBITDA multiples are enterprise value divided by EBITDA; P/E ratios divide share price by net earnings. For small acquisitions, EBITDA multiples are standard because normalized EBITDA smooths out tax and depreciation variations that distort net income. P/E ratios appear more often in public company or private equity analysis where tax structures are standardized.

Should I discount the multiple if I’m going to add debt to the acquisition?

No—the multiple is applied to enterprise value, which is debt-agnostic. What changes is how much equity you deploy. If the enterprise value is $2M at 4.0x EBITDA and you finance $1.5M in debt, you’re paying $500K in equity. The multiple stays the same; your capital structure is the variable.

How much should a multiple change if the business is in a recession-proof sector versus a cyclical one?

Recession-proof or defensive businesses (waste management, healthcare staffing, insurance) typically trade 0.5x to 1.0x higher than cyclical peers (manufacturing, hospitality, retail) because downside revenue risk is lower. In a recession, a defensive business’s EBITDA might fall 10–15%; cyclical businesses can drop 30–50%.

Can a business be “too cheap” at a low multiple?

Absolutely. If you see a business at 2.0x EBITDA when peers trade at 3.5x, don’t celebrate—dig. High leverage, persistent customer churn, outdated tech, or litigation risk are common culprits. A bargain multiple often reflects risk the seller isn’t disclosing; your job is to identify what that risk is before signing the LOI.

How do I know if a seller’s “adjusted EBITDA” is honest?

Request two years of tax returns and internal P&Ls, then reconcile them yourself. Add-backs should be documented—supplier invoices, contracts showing expiration, payroll records. Ask the seller to commit: “If this add-back doesn’t materialize post-close, the purchase price adjusts down.” Honest sellers will agree; those resisting are hiding something.

This article is educational and does not constitute M&A, investment, or accounting advice — confirm findings with a licensed CPA or M&A advisor before making an offer.

This article is educational and does not constitute M&A, investment, or accounting advice — confirm findings with a licensed CPA or M&A advisor before making an offer.

See how IncomeReady organizes normalized EBITDA and SDE before you make an offer.